Viewing Study NCT04488705


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2025-12-26 @ 2:14 AM
Study NCT ID: NCT04488705
Status: COMPLETED
Last Update Posted: 2021-05-21
First Post: 2020-07-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
Sponsor: Enterprise Therapeutics Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module